Greenwich LifeSciences, Inc.
(NASDAQ: GLSI)

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

28.590 -

-4.975 (-14.82%)
Range 28.590 - 33.310   (16.51%)
Open 32.910
Previous Close 33.565
Bid Price -
Bid Volume -
Ask Price -
Ask Volume -
Volume 395,335
Value 7,658,420
Remark -
Delayed prices. Updated at 29 Jan 2026 09:15.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis